Zhongnan Medical Journal Press

Home Results

A total of 6 result was found. Results that relate to Targeted therapy

The role of interleukin-8 in the development and progression of prostate cancer

Published on New Medicine 2021,31(1):383-389.
5095 times 2496 times

Sheng WANG Xing-Yu XIONG Lu YANG

Prostate cancer Interleukin-8 Targeted therapy
Details
Progress in molecular pathology and targeted therapy of pulmonary sacromatiod carcinoma

Published on New Medicine 2021,31(1):138-144.
10584 times 3512 times

Yu-Wei DING Xiu-Jun TANG Yi CHENG Ning ZHU Shan-Shan WENG Ying YUAN

Pulmonary sacromatiod carcinoma Targeted therapy Molecular pathology Precision medicine Immunotherapy
Details
Chronic disease management is a new model in the treatment of multiple myeloma

Published on New Medicine 2020,30(1):308-313.
10411 times 3119 times

Peng-Peng LI Fu-Ling ZHOU

Multiple myeloma Chronic disease management Chronic disease Targeted therapy
Details
Expression of ADAM12, MUC3A and MUC17 in gastric cancer and analysis of survival prognosis

Published on Journal of Mathematical Medicine 2024,37(8):600-609.
3312 times 545 times

LI Yuxin GUO Tangxi WEI Yongchang

ADAM12 MUC3A MUC17 Gastric cancer Survival prognosis Targeted therapy
Details
Research hotspots and future trends of drug resistance mechanism in treatment of renal cell carcinoma based on bibliometric analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1276-1295.
1340 times 249 times

ZHENG Xinyi XU Jiajun QIU Xiaoyan

Renal cell carcinoma Drug resistance Targeted therapy Immunotherapy Bibliometric analysis Visualization
Details
Application progress of novel targeted drugs in precision treatment of membranous nephropathy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):467-473.
50 times 13 times

CHEN Wei LI Xiaowei

Membranous nephropathy Refractory membranous nephropathy Targeted therapy Anti-CD20 monoclonal antibodies Anti-B-cell activating factor monoclonal antibodies Anti-CD38 monoclonal antibodies Proteasome inhibitors Complement inhibitors Individualized treatment
Details